Our research team assigns Bronze ratings to strategies ... The healthcare overweighting was driven mainly by medical device-makers, with Globus Medical and Baxter added in the past year.
Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...
In a report released today, Matt Miksic from Barclays maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target ...
Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement ...
Following strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire ... a personalised pain management platform that uses AI. The company also sells ...
Stifel Nicolaus boosted their price objective on Globus Medical from $80.00 to $92.00 and gave the company a “buy” rating in a report on Wednesday, November 6th. Roth Mkm boosted their price ...
GlobalData on MSN4d
Globus Medical strengthens SCS market position with $250m Nevro dealGlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback